Long-term safety and limited organ damage in patients with systemic lupus erythematosus treated with belimumab: a Phase III study extension

OBJECTIVE: This extension study of the Phase III, randomized, placebo-controlled Belimumab International SLE Study (BLISS)-52 and BLISS-76 studies allowed non-US patients with SLE to continue belimumab treatment, in order to evaluate its long-term safety and tolerability including organ damage accru...

Descripción completa

Detalles Bibliográficos
Autores principales: van Vollenhoven, Ronald F, Navarra, Sandra V, Levy, Roger A, Thomas, Mathew, Heath, Amy, Lustine, Todd, Adamkovic, Anthony, Fettiplace, James, Wang, Mei-Lun, Ji, Beulah, Roth, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571485/
https://www.ncbi.nlm.nih.gov/pubmed/31302695
http://dx.doi.org/10.1093/rheumatology/kez279

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571485/
https://www.ncbi.nlm.nih.gov/pubmed/31302695
http://dx.doi.org/10.1093/rheumatology/kez279

Ejemplares similares